Share

June 15, 2021; 96 (24) Editorial

Early Diagnosis of Multiple Sclerosis

Further Evidence for Missed Opportunity

Andrew J. Solomon, Alberto Ascherio
First published April 26, 2021, DOI: https://doi.org/10.1212/WNL.0000000000012087
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
194

Share

Article Information

vol. 96 no. 24 1111-1112
DOI: 
https://doi.org/10.1212/WNL.0000000000012087
PubMed: 
33903189
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 26, 2021.

Article Versions

Copyright & Usage: 
© 2021 American Academy of Neurology

Author Disclosures

    1. Andrew J. Solomon, MD and
    2. Alberto Ascherio, MD, DrPH
  1. Andrew J. Solomon, MD and
    2. Scientific Advisory Boards:

    1. Serono, Genentech, Biogen, Alexion, Celgene, and Greenwich Biosciences

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Section Editor, Teaching Section, Mult Scler Relat Disord

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. compensation for non-promotional speaking from EMD Serono

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Biogen

    Research Support, Government Entities:

    1. NIH/NNINDS, K02NS109340 2019-2021 PI

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Alberto Ascherio, MD, DrPH
    3. Scientific Advisory Boards:

    1. University of Rochester - Scientific Advisory Board of NIH-funded study "At-Home PD"

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. NorthShore University HealthSystem, Evanston IL, 2019. Honorarium for talk on neurodegenerative diseases. University of Oslo, Norway. Honorarium as PhD defense opponent.

    Editorial Boards:

    1. 1) Journal of Parkinson Disease, Editorial board

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH R01 NS073633; 2011-2017; Role: PI DoD W81XWH-14-1-0131; 2014-2019; Role: PI NIH R01 NS045893; 2013-2018; Role: PI NIH 1U01NS-90259; 2015-2020; Role: PI of subcontract NIH R01 NS089619-01A1; 2015-2020; Role: PI NIH R01 NS097723; 2016-2021; Role: Co-Investigator NIH R01 NS103891; 2018-2023; Role: PI CDMRP MS170116; 2018-2021; Role: PI

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. ALS Association; 2019-2020; Role: PI

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurological Sciences (A.J.S.), Larner College of Medicine at the University of Vermont, Burlington; Department of Nutrition (A.S.), Harvard T. H. Chan School of Public Health; and Channing Division of Network Medicine (A.S.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
  1. Correspondence
    Dr. Solomon Andrew.Solomon{at}uvm.edu
View Full Text

Article usage

Article usage: April 2021 to December 2022

AbstractFullPdfSource
Apr 20210015Highwire
May 20210034Highwire
Jun 20218578950Highwire
Jul 20212682019Highwire
Aug 20212691015Highwire
Sep 2021173115Highwire
Oct 2021160119Highwire
Nov 2021167612Highwire
Dec 202110131Highwire
Jan 202213943Highwire
Feb 202221233Highwire
Mar 202211434Highwire
Apr 20228552Highwire
May 20228733Highwire
Jun 20224753Highwire
Jul 20227705Highwire
Aug 20226801Highwire
Sep 20225020Highwire
Oct 20227097Highwire
Nov 20226831Highwire
Dec 20226212Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me